The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 340:1071-1074 April 8, 1999 Number 14
NextNext

Recurrence of Bronchioloalveolar Carcinoma in Transplanted Lungs
Robert I. Garver, M.D., George L. Zorn, M.D., Xing Wu, Ph.D., David C. McGiffin, M.D., K. Randall Young, M.D., and Nanette B. Pinkard, M.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Bronchioloalveolar carcinoma is a distinctive subtype of typical adenocarcinoma of the lung that tends to metastasize widely throughout the lungs but less commonly elsewhere. Because conventional therapies for intrapulmonary metastatic bronchioloalveolar carcinoma are generally ineffective, we treated seven patients who had intrapulmonary metastatic bronchioloalveolar carcinoma with lung transplantation.

Methods Seven patients with biopsy-proved bronchioloalveolar carcinoma and no evidence of extrapulmonary disease received transplants of either one or two cadaveric lungs. At transplantation, all native lung tissue was removed and replaced with a donor lung or lungs. The patients received the usual post-transplantation care given at the institution.

Results Four of the seven patients had recurrent bronchioloalveolar carcinoma within the donor lungs; the recurrences appeared from 10 to 48 months after transplantation. All recurrences were limited to the donor lungs. Histologic and molecular analyses showed that the recurrent tumors in three patients originated from the recipients of the transplants.

Conclusions Lung transplantation for bronchioloalveolar carcinoma is technically feasible, but recurrence of the original tumor within the donor lungs up to four years after transplantation was common.


Source Information

From the Departments of Medicine (R.I.G., X.W., K.R.Y.), Surgery (G.L.Z., D.C.M.), and Pathology (N.B.P.), University of Alabama at Birmingham; and the Lung Transplant Program (G.L.Z., D.C.M., K.R.Y.) and Lung Cancer Program (R.I.G., G.L.Z.), UAB Hospital, Birmingham, Ala.

Address reprint requests to Dr. Garver at the School of Medicine, University of Alabama at Birmingham, 701 South 19th St./LHRB 339, Birmingham, AL 35294, or at robgarver{at}sprintmail.com.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.